Leadless Pacing: Where We Currently Stand and What the Future Holds

[1] Kusumoto FM(2019)2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Circulation 140 e382-e482

[2] Schoenfeld MH(2014)Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark Eur Heart J 35 1186-1194

[3] Barrett C(2012)Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study Heart Rhythm 9 728-735

[4] Kirkfeldt RE(2017)Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment JACC Clin Electrophysiol 3 1296-1305

[5] Johansen JB(2018)Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers Heart Rhythm 15 1023-1030

[6] Nohr EA(2018)Leadless pacemaker versus transvenous single-chamber pacemaker therapy: a propensity score-matched analysis Heart Rhythm 15 1387-1393

[7] Jorgensen OD(2016)A leadless intracardiac transcatheter pacing system N Engl J Med 374 533-541

[8] Nielsen JC(2018)Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control Heart Rhythm 15 1800-1807

[9] Udo EO(2017)Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study Heart Rhythm 14 702-709

[10] Zuithoff NP(2022)Primary results on safety and efficacy from the LEADLESS II-Phase 2 worldwide clinical trial JACC Clin Electrophysiol 8 115-117

[1] Kusumoto FM(2019)2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Circulation 140 e382-e482

[2] Schoenfeld MH(2014)Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark Eur Heart J 35 1186-1194

[3] Barrett C(2012)Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study Heart Rhythm 9 728-735

[4] Kirkfeldt RE(2017)Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment JACC Clin Electrophysiol 3 1296-1305

[5] Johansen JB(2018)Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers Heart Rhythm 15 1023-1030

[6] Nohr EA(2018)Leadless pacemaker versus transvenous single-chamber pacemaker therapy: a propensity score-matched analysis Heart Rhythm 15 1387-1393

[7] Jorgensen OD(2016)A leadless intracardiac transcatheter pacing system N Engl J Med 374 533-541

[8] Nielsen JC(2018)Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control Heart Rhythm 15 1800-1807

[9] Udo EO(2017)Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study Heart Rhythm 14 702-709

[10] Zuithoff NP(2022)Primary results on safety and efficacy from the LEADLESS II-Phase 2 worldwide clinical trial JACC Clin Electrophysiol 8 115-117